Neck Cancer Current Events

Neck Cancer Current Events, Neck Cancer News Articles.
Sort By: Most Viewed | Most Recent
Page 1 of 25 | 1000 Results
Combination therapy spares some head and neck patients from surgery
Giving patients with head and neck cancer a combination of chemotherapy and radiation therapy controls the cancer and allows many patients to avoid additional surgery to the neck, according to a study presented at the plenary session today at the Multidisciplinary Head and Neck Cancer Symposium in Rancho Mirage, Calif., co-sponsored by the American Society for Therapeutic Radiology and Oncology, the American Society of Clinical Oncology and the American Head and Neck Society. (2007-01-19)

Smoking increases risks for head and neck cancers for men and women
A large, prospective study confirmed strong associations between current and past cigarette smoking and malignancies of the head and neck in both genders. (2007-08-27)

Tobacco and alcohol use independently increase risk of head and neck cancer
Cigarette smoking is more strongly associated with head and neck cancers than drinking alcohol, according to a study in the May 16 issue of the Journal of the National Cancer Institute. The study found that smoking is responsible for a quarter of head and neck cancers among individuals who do not drink alcohol. (2007-05-15)

Certain head and neck cancer patients benefit from second round of treatment
A new study has determined predictors that can better identify patients who will benefit from a potentially toxic second course of treatment, which offers a small but real chance of cure in select patients with head and neck cancer. (2011-06-13)

University of Cincinnati research unveils possible new combo therapy for head and neck cancer
Researchers at the University of Cincinnati have tested a new combination therapy in animal models to see if they could find a way to make an already effective treatment even better. Since they're using a Food and Drug Administration-approved drug to do it, this could help people sooner than later. (2021-01-22)

JAMA publication features study on depression and head and neck cancer
A new study shows that antidepressants can significantly reduce the risk of depression for head and neck cancer patients. The study, conducted at the University of Nebraska Medical Center, found that only 15 percent of head and neck cancer patients who took antidepressants as part of their treatment experienced depression, while 50 percent of the patients in the study group who didn't take antidepressants experienced depression. (2008-05-19)

Early morning smokers have increased risk of lung and head and neck cancers
Two new studies have found that smokers who tend to take their first cigarette soon after they wake up in the morning may have a higher risk of developing lung and head and neck cancers than smokers who refrain from lighting up right away. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the results may help identify smokers who have an especially high risk of developing cancer and would benefit from targeted smoking interventions to reduce their risk. (2011-08-08)

$12 Million SPORE grant spurs head and neck cancer research
The University of Texas M. D. Anderson Cancer Center has been awarded its fifth SPORE grant from the National Cancer Institute, a $12 million grant for head and neck cancer research. (2002-10-10)

Liposuction for the management of submental lymphedema in the head and neck cancer patient
Liposuction is a novel and minimally invasive procedure for treating persistent submental lymphedema in patients with previous head and neck cancer, according to an article published in the June 2012 issue of Otolaryngology-Head and Neck Surgery. (2012-06-12)

Use of mood-stabilizing drug linked with reduced risk of developing head and neck cancer
A new study indicates that a commonly used mood stabilizing drug may help prevent head and neck cancer. The study is published early online in Cancer, a peer-reviewed journal of the American Cancer Society. (2014-03-24)

Pitt Researchers Find Way To Block Cellular Growth Pathways And Inhibit Tumor Growth
At the annual American Association of Cancer Research meeting in New Orleans, University of Pittsburgh Cancer Institute researchers are presenting exciting evidence from animal models that blocking two cellular growth pathways causes tumor cells to die. (1998-03-31)

Free head, neck cancer screenings have positive impact in urban areas
Offering free head and neck cancer screenings annually to the community not only has the possibility of early detection, but also the opportunity -- particularly in an urban city -- to increase a person's understanding of risk factors that cause cancer, according to a new study from Henry Ford Hospital in Detroit. (2013-10-02)

New surgery improves head and neck cancer treatment
Latest robotics surgery trend has made its debut in the ear, nose and throat specialty, where cancer and otolaryngology surgeons say the like the improved accuracy. Patients benefit from reduced post-op pain and shorter recoveries, say researchers at the University of Alabama at Birmingham. Adaptations to the robot procedure are needed for head & neck cases. (2008-04-29)

Study finds 231 new genes associated with head and neck cancer
A Henry Ford Hospital study has identified 231 new genes associated with head and neck cancer, one of the most deadly cancers responsible for 2.1 percent of all cancer deaths in the United States. Results will be presented Sunday, Oct. 4, at the American Academy of Otolaryngology -- Head & Neck Surgery Foundation Annual Meeting & OTO EXPO in San Diego. (2009-10-04)

NIH grant using genomics to tailor oral cancer treatment NYU College of Dentistry, UC San Francisco
The National Cancer Institute, NIH, has awarded a two-year grant to NYU College of Dentistry's Dr.Schmidt and UCSF's Dr. Albertson. The grant will fund groundbreaking research to customize treatment for oral cancer patients. Drs. Schmidt and Albertson have identified candidate genomic markers in tumors that predict if an oral cancer is likely to spread to the neck. (2012-04-27)

Phase 1 clinical trial of CUDC-101 'throws kitchen sink' at head and neck cancer
At 18 months median follow up, one patient's cancer had worsened, two had died, and nine remained free of disease. Testing of blood and tumor samples showed that CUDC-101 had indeed inhibited the action of EGFR, HDAC and Her2. (2015-01-26)

Protein holds back growth of head and neck tumors
A protein associated with the growth of head and neck tumors may serve as a tumor suppressor that could prevent the spread of cancer when it is expressed above normal levels, according to a study published in the Feb. 1 issue of the Journal of the National Cancer Institute. The University of Pittsburgh study is the first to discover that the protein, STAT1, may play a vital role in preventing head and neck tumor growth. (2006-01-31)

Small study shows marijuana does not increase risk of head, neck cancer
Smoking marijuana does not increase the user's risk of head and neck cancer, according to a new study published in the March 2008 issue of Otolaryngology -- Head and Neck Surgery. (2008-03-04)

Combining radiation and surgery significantly improves survival for head and neck cancer patients
Adding radiation therapy to surgery significantly improves overall survival in patients diagnosed with node-positive head and neck cancer when compared to treating with surgery alone, according to a study in the June issue of the International Journal of Radiation Oncology, Biology, Physics, the official journal of the American Society for Therapeutic Radiology and Oncology. (2008-06-09)

Faster radiotherapy more effective in head and neck cancer, trial shows
The world's largest trial in accelerated radiotherapy for head and neck cancer - the DAHANCA trial - proves conclusively that increasing the number of treatments per week from five to six can benefit patients. Research to be published in The Lancet (20 September issue) and presented at ECCO 12 - the European Cancer Conference (21-25 September). (2003-09-18)

U-Michigan scientists observe deadly dance between nerves and cancer cells
In certain types of cancer, nerves and cancer cells enter an often lethal and intricate waltz where cancer cells and nerves move toward one another and eventually engage in such a way that the cancer cells enter the nerves. (2015-04-28)

Head & neck cancer in transplant patients: For better or worse?
Transplant patients who develop head and neck cancer are more likely to be non-smokers and non-drinkers, and less likely than their non-transplant counterparts to survive past one year of diagnosis, according to a new study from Henry Ford Hospital in Detroit. (2012-01-27)

Stress and neck pain more common in women than men
Neck pain is more common in women than men, irrespective of occupation or age. Stressed young women develop more neck pain than their male counterparts. Women also perceive everyday life to be more stressful, reveals a thesis from the University of Gothenburg, Sweden. (2010-12-06)

Intravenous chemoradiation effective for inoperable head, neck cancer; easier for patients, doctors
Chemoradiation (radiation and chemotherapy given at the same time) given through a needle or tube inserted into a vein (intravenous) is as effective as treatment given directly to the tumor through a tube inserted into an artery (intra-arterial) for patients with inoperable head and neck cancer, according to a randomized study presented at the plenary session November 6, 2006, at the American Society for Therapeutic Radiology and Oncology's 48th Annual Meeting in Philadelphia. (2006-11-06)

ASTRO names leading head and neck surgeon honorary member
The American Society for Therapeutic Radiology and Oncology is pleased to announce that Randal S. Weber, M.D., F.A.C.S., has been chosen as an honorary member of the society. Dr. Weber will receive his award during an awards ceremony at the 49th annual meeting to be held October 28 through November 1, 2007, at the Los Angeles Convention Center in Los Angeles. (2007-07-16)

OHSU researcher develops first animal model to treat devasting head and neck cancers
An Oregon Health & Science University Cancer Institute research laboratory has developed a novel mouse model designed specifically to study the often devastating head and neck squamous cell cancers. Xiao-Jing Wang, MD, PhD, and colleagues report their research breakthrough in the May 15 issue of Genes & Development. (2006-05-14)

Advanced radiation therapy for head and neck cancer may be better than traditional radiation at preventing side effects and cancer recurrence
Patients with head and neck cancer who are treated with an advanced form of radiation therapy may experience fewer side effects and be less likely to die from their disease than patients who receive standard radiation therapy. That is the finding of an analysis published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The study establishes so-called intensity-modulated radiation therapy as both a safe and beneficial treatment for patients with head and neck cancer. (2014-01-13)

Quality of life associated with long-term survival in patients with head and neck cancer
Quality of life measured one year after treatment for head and neck cancer appears to be associated with longer-term survival, according to a study in the January issue of Archives of Otolaryngology - Head & Neck Surgery, one of the JAMA/Archives journals. (2006-01-16)

New treatment combination proves safe for head and neck cancer patients
Patients undergoing treatment for advanced head and neck cancers may respond well to the addition of gefinitib to chemotherapy, according to a study sponsored by the Eastern Cooperative Oncology Group and chaired by Ethan Argiris, M.D., associate professor of medicine, University of Pittsburgh School of Medicine. The results will be disclosed at the 45th annual meeting of the American Society of Clinical Oncology on May 30 in Orlando, Fla. (2009-05-30)

Promising breath-test for cancer
The global quest to use a person's breath analysis for rapid, inexpensive and accurate early-stage testing for cancer and other diseases has taken a leap forward. In a new paper in the British Journal of Cancer, Flinders University researchers have reported significant progress in developing a method to test exhaled breath profiles which accurately differentiate head and neck cancer from non-cancer patients. (2020-10-05)

Compound in magnolia may combat head and neck cancers
As one of the compounds in magnolia extract, honokiol has been used for centuries in traditional Chinese and Japanese medicine to treat anxiety and other conditions. More recently, scientists, including a team with the Department of Veterans Affairs and the University of Alabama at Birmingham, have been revealing its cancer-fighting properties. (2015-06-25)

Protein associated with lung cancer linked for the first time to head and neck cancer
Researchers from the University of Pittsburgh Cancer Institute are the first to find that the protein gastrin-releasing peptide receptor (GRPR), know to be associated with lung cancer, is linked to the proliferation of squamous cell carcinoma of the head and neck. The results, published in the March 6 issue of the Journal of the National Cancer Institute, are significant because they suggest that receptor-directed therapies for head and neck cancer patients may result in very useful anti-cancer strategies for patients. (2002-03-06)

Combining CT, FDG-PET provides more accurate treatments for head and neck cancer patients
Combining computerized tomography (CT) with fluorodeoxyglucose positron emission tomography (FDG-PET) images results in significantly more defined tumor outlines and potentially different treatment options in head and neck cancer patients compared to using CT alone, according to research presented today, at the Cancer Imaging and Radiation Therapy Symposium in Atlanta. This symposium is co-sponsored by the American Society for Radiation Oncology (ASTRO) and the Radiological Society of North America (RSNA). (2011-04-29)

Cetuximab with radiotherapy does not increase side effects for head and neck cancer patients
The addition of Cetuximab (brand name Erbitux) to radiation therapy treatments does not increase the rate or duration of some side effects in the treatment of advanced head and neck cancers, according to a study presented at the plenary session today at the Multidisciplinary Head and Neck Cancer Symposium, co-sponsored by the American Society for Therapeutic Radiology and Oncology, the American Society for Clinical Oncology and the American Head and Neck Society. (2007-01-18)

Race could be a factor in head and neck cancer survival rates, MU researchers find
The national survival rates for African-Americans diagnosed with head and neck cancer have not improved in the last 40 years despite advances in the treatment and management of the disease, University of Missouri School of Medicine researchers have found. The researchers suggest that inherent genetic factors in African-Americans may make some tumors resistant to treatments. However, more research needs to be done on the subject of survival disparity in patients with head and neck cancer. (2014-06-05)

Blood marker may reduce cancer burden
Researchers at Flinders University are expanding work on a promising blood test model to help predict or diagnose head and neck cancer, a difficult cancer to pick up early and treat. With cancer accounting for almost 10 million a year, the Global Burden of Disease report (2017) attributed more than 380,000 deaths to head and neck cancer. (2020-09-01)

Some smokers can't quit even after suffering head and neck cancers
Even a bout with head and neck cancer cannot stop some people from smoking, despite many indicating that they want to quit. Head and neck cancer patients who continue to smoke also score substantially lower on measures of quality of life than those who have kicked the habit. (2002-05-03)

Leading research to be highlighted at 2016 Multidisciplinary Head & Neck Cancer Symposium
The 2016 Multidisciplinary Head and Neck Cancer Symposium, sponsored by the American Society for Radiation Oncology (ASTRO), the American Society of Clinical Oncology (ASCO) and the American Head & Neck Society (AHNS), will explore the heterogeneous group of tumors in head and neck cancers and the various complexities and factors in providing treatment. (2016-01-15)

New imaging scans track down persistent cancer cells
Head and neck cancer patients may no longer have to undergo invasive post-treatment surgery to remove remaining cancer cells, as research shows that innovative scanning-led surveillance can help identify the need for, and guidance of, neck dissection. (2016-03-23)

Grape seed extract kills head and neck cancer cells, leaves healthy cells unharmed
A study published this week in the journal Carcinogenesis shows that in both cell lines and mouse models, grape seed extract kills head and neck squamous cell carcinoma cells, while leaving healthy cells unharmed. (2012-01-26)

Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.